Literature DB >> 26929296

Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases.

B Björnsson1, E Sparrelid2, K Hasselgren3, T Gasslander3, B Isaksson2, P Sandström3.   

Abstract

BACKGROUND AND AIMS: Associating liver partition and portal vein ligation for staged hepatectomy may increase the possibility of radical resection in the case of liver malignancy. Concerns have been raised about the high morbidity and mortality associated with the procedure, particularly when applied for diagnoses other than colorectal liver metastases. The aim of this study was to analyze the initial experience with associating liver partition and portal vein ligation for staged hepatectomy in cases of non-colorectal liver metastases and primary hepatobiliary malignancies in Scandinavia.
MATERIALS AND METHODS: A retrospective analysis of all associating liver partition and portal vein ligation for staged hepatectomy procedures performed at two Swedish university hospitals for non-colorectal liver metastases and primary hepatobiliary malignancies was performed. The primary focus was on the safety of the procedure. RESULTS AND
CONCLUSION: Ten patients were included: four had hepatocellular cancer, three had intrahepatic cholangiocarcinoma, one had a Klatskin tumor, one had ocular melanoma metastasis, and one had a metastasis from a Wilms' tumor. All patients completed both operations, and the highest grade of complication (according to the Clavien-Dindo classification) was 3A, which was observed in one patient. No 90-day mortality was observed. Radical resection (R0) was achieved in nine patients, while the resection was R2 in one patient. The low morbidity and mortality observed in this cohort compared with those of earlier reports on associating liver partition and portal vein ligation for staged hepatectomy for diagnoses other than colorectal liver metastases may be related to the selection of patients with limited comorbidity. In addition, procedures other than associating liver partition and portal vein ligation for staged hepatectomy had been avoided in most of the patients. In conclusion, associating liver partition and portal vein ligation for staged hepatectomy can be applied to primary hepatobiliary malignancies and non-colorectal liver metastases with acceptable rates of morbidity and mortality. © The Finnish Surgical Society 2016.

Entities:  

Keywords:  Liver; associating liver partition and portal vein ligation for staged hepatectomy; future liver remnant; hepatocellular cancer; intrahepatic cholangiocarcinoma; liver resection; non-colorectal liver metastases; perihilar cholangiocarcinoma

Mesh:

Year:  2016        PMID: 26929296     DOI: 10.1177/1457496915613650

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  7 in total

1.  The role of ALPPS in intrahepatic cholangiocarcinoma.

Authors:  Jan Bednarsch; Zoltan Czigany; Isabella Lurje; Pavel Strnad; Philipp Bruners; Tom Florian Ulmer; Marcel den Dulk; Georg Lurje; Ulf Peter Neumann
Journal:  Langenbecks Arch Surg       Date:  2019-11-16       Impact factor: 3.445

2.  How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility.

Authors:  Ernesto Sparrelid; Kristina Hasselgren; Bård Ingvald Røsok; Peter Nørgaard Larsen; Nicolai Aagaard Schultz; Ulrik Carling; Eva Fallentin; Stefan Gilg; Per Sandström; Gert Lindell; Bergthor Björnsson
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 7.293

3.  The ALPPS procedure for hepatocellular carcinoma larger than 10 centimeters.

Authors:  Orlando Jorge M Torres; Rodrigo Rodrigues Vasques; Thiago Henrique S Silva; Miguel Eugenio L Castelo-Branco; Camila Cristina S Torres
Journal:  Int J Surg Case Rep       Date:  2016-07-28

4.  Associating liver partition and portal vein ligation for staged hepatectomy in Qatar: Initial experience with two case series and review of the literature.

Authors:  Ibnouf Sulieman; Walid Elmoghazy; Mohammed Said Ghali; Ahmed Mahfouz; Ahmed Elaffandi; Hatem Khalaf
Journal:  Int J Surg Case Rep       Date:  2019-04-06

Review 5.  Outcomes of staged hepatectomies for liver malignancy.

Authors:  Naif A Albati; Ali A Korairi; Ibrahim Al Hasan; Helayel K Almodhaiberi; Abdullah A Algarni
Journal:  World J Hepatol       Date:  2019-06-27

6.  The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma.

Authors:  Lixin Ke; Rui Shen; Wenzhe Fan; Wenjie Hu; Shunli Shen; Shaoqiang Li; Ming Kuang; Lijian Liang; Jiaping Li; Baogang Peng; Yunpeng Hua
Journal:  Ann Transl Med       Date:  2020-11

Review 7.  Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Victor López-López; Ricardo Robles-Campos; Robeto Brusadin; Asunción López-Conesa; Álvaro Navarro; Julio Arevalo-Perez; Pedro Jose Gil; Pascual Parrilla
Journal:  Oncotarget       Date:  2018-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.